Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling…

Full funding of VMX-C001 Phase 3 trial, late-stage product development, manufacturing and pre-launch activitiesVarmX shareholders to receive initial $117m upfront…